Filed: 8/14/2026ACC: 0001104659-26-096837
📋 What this filing means
DECHENG CAPITAL LLC filed this quarterly 13F‑HR report disclosing 14 equity positions with a total reported market value of $731.75M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
14
Positions
$731.75M
Total AUM (reported)
54.31M
Total Shares
Allocation by class
COM$725.10M99.1%
SHS$6.65M0.9%
Portfolio Concentration
Top 3$622.69M85.1%
4–10$95.04M13.0%
11–25$14.02M1.9%
Top 3 weight
85.1%
Top 10 weight
98.1%
Voting Authority Distribution
Total shares with voting rights: 54.31M
Sole
Full voting authority
54.31M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole14
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings14
Rows:
CG ONCOLOGY INC
SOLEShares6.37M
TypeSH
Market value$452.71M
61.87%
Sole
6.37M
Shared
0.00
None
0.00
Nuvation Bio Inc.
SOLEShares25.95M
TypeSH
Market value$147.42M
20.15%
Sole
25.95M
Shared
0.00
None
0.00
AARDVARK THERAPEUTICS INC
SOLEShares3.92M
TypeSH
Market value$22.56M
3.08%
Sole
3.92M
Shared
0.00
None
0.00
Aclaris Therapeutics, Inc.
SOLEShares4.04M
TypeSH
Market value$21.38M
2.92%
Sole
4.04M
Shared
0.00
None
0.00
Upstream Bio Inc.
SOLEShares2.72M
TypeSH
Market value$18.86M
2.58%
Sole
2.72M
Shared
0.00
None
0.00
Arcus Biosciences, Inc
SOLEShares464.78K
TypeSH
Market value$14.33M
1.96%
Sole
464.78K
Shared
0.00
None
0.00
Equillium Inc.
SOLEShares4.45M
TypeSH
Market value$14.23M
1.94%
Sole
4.45M
Shared
0.00
None
0.00
REVOLUTION MEDICINES INC(NSM)
SOLEShares52.67K
TypeSH
Market value$9.86M
1.35%
Sole
52.67K
Shared
0.00
None
0.00
Lyell Immunopharma, Inc.
SOLEShares692.05K
TypeSH
Market value$9.72M
1.33%
Sole
692.05K
Shared
0.00
None
0.00
BeyondSpring Inc.
SOLEShares3.80M
TypeSH
Market value$6.65M
0.91%
Sole
3.80M
Shared
0.00
None
0.00
Zentalis Pharmaceuticals Inc.
SOLEShares1.32M
TypeSH
Market value$6.42M
0.88%
Sole
1.32M
Shared
0.00
None
0.00
NEWAMSTERDAM PHARMA CO NV
SOLEShares176.89K
TypeSH
Market value$5.99M
0.82%
Sole
176.89K
Shared
0.00
None
0.00
Pyxis Oncology, Inc (formerly Apexigen)
SOLEShares326.81K
TypeSH
Market value$983.7K
0.13%
Sole
326.81K
Shared
0.00
None
0.00
TANGO THERAPEUTICS INC
SOLEShares20K
TypeSH
Market value$625.2K
0.09%
Sole
20K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
CG ONCOLOGY INCSOLE | COM | 6.37M | SH | $452.71M 61.87% | 6.37M | 0.00 | 0.00 |
Nuvation Bio Inc.SOLE | COM | 25.95M | SH | $147.42M 20.15% | 25.95M | 0.00 | 0.00 |
AARDVARK THERAPEUTICS INCSOLE | COM | 3.92M | SH | $22.56M 3.08% | 3.92M | 0.00 | 0.00 |
Aclaris Therapeutics, Inc.SOLE | COM | 4.04M | SH | $21.38M 2.92% | 4.04M | 0.00 | 0.00 |
Upstream Bio Inc.SOLE | COM | 2.72M | SH | $18.86M 2.58% | 2.72M | 0.00 | 0.00 |
Arcus Biosciences, IncSOLE | COM | 464.78K | SH | $14.33M 1.96% | 464.78K | 0.00 | 0.00 |
Equillium Inc.SOLE | COM | 4.45M | SH | $14.23M 1.94% | 4.45M | 0.00 | 0.00 |
REVOLUTION MEDICINES INC(NSM)SOLE | COM | 52.67K | SH | $9.86M 1.35% | 52.67K | 0.00 | 0.00 |
Lyell Immunopharma, Inc.SOLE | COM | 692.05K | SH | $9.72M 1.33% | 692.05K | 0.00 | 0.00 |
BeyondSpring Inc.SOLE | SHS | 3.80M | SH | $6.65M 0.91% | 3.80M | 0.00 | 0.00 |
Zentalis Pharmaceuticals Inc.SOLE | COM | 1.32M | SH | $6.42M 0.88% | 1.32M | 0.00 | 0.00 |
NEWAMSTERDAM PHARMA CO NVSOLE | COM | 176.89K | SH | $5.99M 0.82% | 176.89K | 0.00 | 0.00 |
Pyxis Oncology, Inc (formerly Apexigen)SOLE | COM | 326.81K | SH | $983.7K 0.13% | 326.81K | 0.00 | 0.00 |
TANGO THERAPEUTICS INCSOLE | COM | 20K | SH | $625.2K 0.09% | 20K | 0.00 | 0.00 |